FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fresenius Kabi Compounding NORepinephrine Bitartrate 0 Recall

NORepinephrine Bitartrate 0

Fresenius Kabi Compounding, LLC · Canton, MA

Risk level
Class II
Reported by FDA
Oct 30, 2024
Recall ID
D-0020-2025
Check your lot numberHow we source this data

Summary

Fresenius Kabi Compounding recalled NORepinephrine Bitartrate 0 starting Sep 25, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0020-2025 on Oct 30, 2024. Reason: cGMP violations. Status: Terminated.

Why it was recalled

cGMP violations

Product description

NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-027-58

Lot numbers, UPCs & expiration codes

Lot # C274-000038404, exp. date 18-Nov-24

Where it was sold

Product was distributed to 125 direct accounts nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0020-2025
Classification
Class II
Status
Terminated
Recall initiated
Sep 25, 2024
FDA report date
Oct 30, 2024
Quantity
733 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi Compounding, LLC

Original FDA data

Every field from FDA enforcement report D-0020-2025, exactly as published.

Show all FDA fields
City
Canton
State
MA
Status
Terminated
Country
United States
Event ID
95427
Address
20 Dan Rd
Code information
Lot # C274-000038404, exp. date 18-Nov-24
Postal code
02021-2809
Report date
Oct 30, 2024
Product type
Drugs
Recall number
D-0020-2025
Classification
Class II
Recalling firm
Fresenius Kabi Compounding, LLC
Product quantity
733 bags
Termination date
Aug 15, 2025
Reason for recall
cGMP violations
Voluntary / mandated
Voluntary: Firm initiated
Product description
NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-027-58
Distribution pattern
Product was distributed to 125 direct accounts nationwide.
Recall initiation date
Sep 25, 2024
Initial firm notification
Letter
Center classification date
Oct 21, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0020-2025, published Oct 30, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls